← Back
Data updated: Mar 29, 2026
MDD US
Neurology
Pharma
MDD US is a pharmaceutical company focused on Neurology. Key products include XADAGO.
2004
Since
3
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
ONAPGO 2025-02-03
Type 5 - New Formulation or New Manufacturer
APOKYN 2025-02-03
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
2 drugs Phase 3: 1 Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...